June 2021
Volume 62, Issue 8
Open Access
ARVO Annual Meeting Abstract  |   June 2021
A comparison of perception of pain in patients receiving neurolept anesthesia at 2 different time points for refractive laser assisted cataract surgery
Author Affiliations & Notes
  • Rishi B Gupta
    University of Ottawa Faculty of Medicine, Ottawa, Ontario, Canada
  • Eric Tam
    University of Toronto, Toronto, Ontario, Canada
  • Hannah Chiu
    University of Toronto, Toronto, Ontario, Canada
  • Rajiv Maini
    University of Toronto, Toronto, Ontario, Canada
  • Ileana Gold
    University of Toronto, Toronto, Ontario, Canada
  • Sohel Somani
    University of Toronto, Toronto, Ontario, Canada
  • Footnotes
    Commercial Relationships   Rishi Gupta, None; Eric Tam, Johnson & Johnson (C); Hannah Chiu, Bayer (S), Novartis (S); Rajiv Maini, None; Ileana Gold, None; Sohel Somani, Allergan (R), Bayer (R), Novartis (R), Novartis (S)
  • Footnotes
    Support  None
Investigative Ophthalmology & Visual Science June 2021, Vol.62, 588. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Rishi B Gupta, Eric Tam, Hannah Chiu, Rajiv Maini, Ileana Gold, Sohel Somani; A comparison of perception of pain in patients receiving neurolept anesthesia at 2 different time points for refractive laser assisted cataract surgery. Invest. Ophthalmol. Vis. Sci. 2021;62(8):588.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : The purpose of this study is to assess the impact of neurolept anesthesia administration timing on the perception of pain in patients undergoing refractive laser-assisted cataract surgery (ReLACS).

Methods : This is a prospective REB randomized control trial at an ambulatory surgical center in Toronto, Ontario, Canada. Patients undergoing cataract surgery were selected in a consecutive manner. Patients were randomized to either receiving neurolept anesthesia following completion of the ReLACS procedure and just prior to draping the eye (standard, n = 38), or, prior to the initiation of the ReLACS procedure (early, n = 35). Primary outcome metrics included pain scores on the visual analogue scale (VAS) from zero (no pain) to ten (unbearable pain) at post-operative day zero (POD0) and post-operative week one (POW1). Secondary outcome measures included a State-Trait Anxiety Inventory (STAI) pre-operative anxiety questionnaire (measured on a scale of 20-80), surgeon and anesthesiologist patient cooperation scores measured on a scale of zero (no event) to three (marked eye and head movement and lid squeezing), ocular metrics (anterior chamber depth, intraocular pressure, surgical time, phacoemulsification energy), and perioperative vitals.

Results : Mean pain scores of early and standard groups at POD0 were 0.59 and 0.79 (p = 0.38), respectively, and at POW1 were 0.76 and 0.87 (p = 0.71), respectively. Linear regression analysis of pain scores incorporating all independent variables (ocular metrics and perioperative vitals) between both groups were also not statistically significant at POD0 (p = 0.40) and POW1 (p = 0.17). In all patients, each 1 mm increase of anterior chamber depth caused an increase of 1.23 pain units (p = 0.02) at POW1. For pain scores at POW1 in all patients, the second eye had an increase of 0.70 pain units (p = 0.02) relative to the first eye.

Conclusions : In patients undergoing refractive laser assisted cataract surgery, there was no difference in pain scores between early and standard timing of neurolept anesthesia administration at both POD0 and POW1. Patients perceived increased levels of pain in the second eye at POW1 relative to their first eye. Furthermore, an increase in ACD was also strongly correlated with an increase in pain scores at POW1.

This is a 2021 ARVO Annual Meeting abstract.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×